Literature DB >> 6532184

Pharmacokinetic study of 3H-labelled PAF-acether II. Comparison with 3H-labelled lyso-PAF-acether after intravenous administration in the rabbit and protein binding.

C Lartigue-Mattei, D Godeneche, J L Chabard, J Petit, J A Berger.   

Abstract

The blood and plasma kinetics of intravenously administered 3H-labelled PAF-acether were determined in seven rabbits. PAF-acether was rapidly distributed and slowly eliminated. Individual variations were very small. The main route of metabolism involves deacetylation of the PAF-acether into lyso-PAF-acether, leading to an equilibrium between the two molecules (10%/90%). This equilibrium, observed within 30 minutes, was still the same after 6 hours suggesting in vivo reacetylation of lyso-PAF-acether into PAF-acether. However, this could not be verified. After intravenous administration of lyso-PAF-acether in two rabbits, PAF-acether could not be found in any blood sample. The pharmacokinetic behaviour of both PAF-acether and lyso-PAF-acether can be described by a three-compartment model.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6532184     DOI: 10.1007/bf01966786

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  6 in total

1.  [Calculation of initial values of pharmacokinetic using a programmable calculator].

Authors:  P P Le Blanc; J Dumas
Journal:  Therapie       Date:  1983 Jan-Feb       Impact factor: 2.070

2.  Biosynthesis of platelet-activating factor (PAF)acether). III. Formation of PAF-acether from synthetic substrates by stimulated murine macrophages.

Authors:  J M Mencia-Huerta; R Roubin; J L Morgat; J Benveniste
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

3.  A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid).

Authors:  M L Blank; T Lee; V Fitzgerald; F Snyder
Journal:  J Biol Chem       Date:  1981-01-10       Impact factor: 5.157

4.  Pharmacokinetic study of PAF-acether. Preliminary results after the intravenous administration of a 3H-labelled product to the rabbit.

Authors:  C Lartigue-Mattei; D Godeneche; J L Chabard; J A Berger
Journal:  Agents Actions       Date:  1982-12

5.  Conversion of 3H-PAF acether by rabbit platelets is independent from aggregation: evidences for a novel metabolite.

Authors:  L Touqui; C Jacquemin; B B Vargaftig
Journal:  Biochem Biophys Res Commun       Date:  1983-02-10       Impact factor: 3.575

6.  Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor.

Authors:  J Benveniste; P M Henson; C G Cochrane
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

  6 in total
  2 in total

1.  Eosinophil accumulation in pulmonary airways of guinea-pigs induced by exposure to an aerosol of platelet-activating factor: effect of anti-asthma drugs.

Authors:  S Sanjar; S Aoki; K Boubekeur; I D Chapman; D Smith; M A Kings; J Morley
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

Review 2.  PAF antagonists. Their potential therapeutic role in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Drugs       Date:  1988-02       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.